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a b s t r a c t
Since more than 10 years, risk assessment of bisphenol A (BPA) is debated at the international level. In
2008, the U.S. National Toxicology Program (NTP) expressed some concern for adverse effects, at current
level of exposure to BPA, on developmental toxicity. In this context, the French Food Safety Agency
(AFSSA) decided to review the toxicity data on BPA with a special focus on this endpoint at doses below
5mg/kg bw/day (the no observed adverse effect level set by different regulatory bodies). This paper
summarizes the conclusions of a collective assessment conducted by an expert Working Group from
AFSSA. Studies were classified into 3 groups: (i) finding no toxicity, (ii) reporting results not considered
to be of concern and (iii) indicating warning signals. The term “warning signal” means that no formal
conclusion can be drawn regarding the establishment of a health based guidance value but the study
raises some questions about the toxicity of BPA at low doses. It was concluded that studies are needed
to ascertain the significance for human health of these warning signals and to be able to propose new
methodologies for assessing the risks associated with low doses of BPA and more generally of endocrine
disruptors.
Introduction
Bisphenol A [2,2-bis(4-hydroxyphenyl)propane] is used for
many years as a monomer to produce (via polymerisation) poly-
carbonate and epoxy resins for coatings. Rigid and transparent
polycarbonates are used in numerous food containers, such as
reusable water bottles, baby bottles, tableware (plates and cups)
and storage containers. Epoxy coatings are used inside food cans,
pipes and tanks for drinking water and food industry.
In Europe, the tolerable daily intake (TDI) for BPA is 0.05mg/kg
body weight (bw)/day. It has been set by the European Food Safety
Authority (EFSA) in 2006 (and confirmed in 2010) based on a No
ObservedAdverse Effects Level (NOAEL) of 5mg/kg bw/day derived
from liver toxicity in a two-generation reproductive toxicity study
in mice (Tyl et al., 2008) and using an uncertainty factor of 100
(EFSA, 2006, 2008, 2010) based on liver toxicity and using an
uncertainty factor of 100. However, several studies suggest various
effects at doses lower than 5mg/kg bw/day. The starting point was
the conclusion of the U.S. National Toxicology Program (NTP, 2008)
which expressed some concern for adverse effects, at current level
of exposure to BPA, on developmental toxicity for fetuses, infants
and children (effects on the brain, behaviour and prostate gland).
Such results lead to controversy on the risk assessment of BPA with
opposite statements between those considering that there is no
risk at the current levels of exposure and those acknowledging a
risk even at very low levels, especially for babies, related to the
weak estrogenic activity of BPA.
To establish if previous assessments performed by AFSSA on
BPA should beupdated regarding toxicity of this compound (AFSSA,
2008a,b, 2009), the French Agency decided to perform a thorough
review of a recent rat dietary neurodevelopmental toxicity study
(Stump, 2009), complying with international guideline standards
from OECD and U.S. EPA and designed to detect morphological
and functional abnormalities (learning, memory, etc) from birth
to adulthood. Other recently published data on the toxic effects
of BPA and on the human exposure to this compound were also
included. AFSSA set an ad hoc Working Group (WG) to perform this
review through a collective assessment. This paper reports the key
points of thiswork on themost relevant toxicity studies of BPA. The
detailed assessment and comments are available in AFSSA’s Opin-
ion dated 29 January 2010 on the critical analysis of the results of
a developmental neurotoxicity study of bisphenol A together with
other recently published data on its toxic effects and in its Annex
dated 31 May 2010 (AFSSA, 2010a,b).
Methods
AFSSA set a Working Group (WG) constituted of experts from
three different scientific panels (on Food Contact Materials, on
Residues and Physico-Chemical Contaminants in Food, on Pesti-
cides), and one external expert experienced in BPA and endocrine
disruptors. All the experts who are members of scientific panels
were selected based on their scientific competence, their expertise
and their declared interests by a specific board constituted of inde-
pendent external evaluators and of AFSSA staff. Their declarations
of interests are available on AFSSA’s website. The external expert
hasbeenselectedaccording to its specific competencesandsigneda
declaration of interests before the start of theWG.Moreover, AFSSA
has developed guidelines of good practice for risk assessment to
guide the work of its experts. The opinions and reports are the out-
come of collective deliberations, each expert is invited to express
its view and minority positions are recorded.
The WG on BPA focused its work on published in vivo toxic-
ity studies, with special interest for those assessing effects at low
doses, and mainly on behavioural and reproductive effects. Studies
on human biomonitoring and exposure were also considered, but
not in vitro studies. The goal was not to be exhaustive but to ana-
lyze the studies that seemed to be most relevant for a dietary risk
assessment.
Literature searched has been performed mainly by MED-
LINE/PubMed and SCOPUS using “bisphenol A” in all fields (title,
abstract, text), restricted to the mid-2009 to January 2010. Few
older referenceswere added to ensure a complete understanding of
the recent datawhenneeded. Reviewpapers submitted by a French
NGO, which has been invited to present its view, were also taken
into account.
Methodological aspects (route of exposure, number of animals
per group, number of doses, dose levels, use of positive controls,
etc.), housing conditions of animals (use of polycarbonate drinking
bottle, choice of bedding, presence of phytoetrogens in diet, etc.)
along with the consistency of the results of each study were sum-
marized and commented by the experts. Each study was reviewed
by at least two experts and discussed collectively during meetings
of the WG. The overall quality of the studies was quoted accord-
ing to the criteria proposed by Klimish et al. (1997) for assessing
reliability, relevance, and adequacy of data.
The conclusions of the WG were discussed and adopted by two
scientific panels of the French Agency (Food Contact Materials and
Residues and Physico-Chemical Contaminants in Food).
Results and discussion
The WG identified 52 relevant studies among which 28 were
dedicated to BPA toxicity (experimental studies or review papers)
and 24 were related to human exposure (release from baby bottles,
cans, and biomonitoring data). The toxicity studies were catego-
rized by the WG as (i) finding no toxicity, (ii) reporting results not
considered to be of concern and (iii) indicating warning signals.
The term “warning signal” means that no formal conclusion can
be drawn regarding the establishment of a health based guidance
value but the study raises some questions about the toxicity of BPA
at low doses.
Studies finding no toxicity of BPA
The Stump’s study (2009), complying with international guide-
line standards from OECD and U.S. EPA, was performed in rat pups
born from dams orally treated at 0.15, 1.5, 75, 750, and 2250mg/kg
diet per day. Results did not show any effect on auditory star-
tle, motor activity, learning and memory using the Biel water
maze, brain and nervous system neuropathology, brain morphom-
etry. The author set the NOAEL at 75mg/kg diet (equivalent to
5.85mg/kg bw/day) based on reduced maternal and offspring body
weights.
In rat pups from dams treated by gavage at 2, 20 or 200g/kg
bw/day, Ryan et al. (2010) did not notice any effect on female
anogenital distance, pups bodyweights, age at vaginal opening, F1
fertility, F2 litter sizes, malformations, female saccharin preference
and lordosis behaviour. In addition, Howdeshell et al. (2008), in
the same study performed in males, did not observe any effect on
male anogenital distance, pups bodyweights, androgen-dependent
tissue weights and epididymal sperm counts.
Studies reporting results not considered to be of concern
The following studies analyzed by the WG were not consid-
ered relevant for risk assessment because of major methodological
flaws, the lack of consistency in the results, the overall poor qual-
ity of the protocol or because the conclusions given by the authors
were not totally supported by the data.
Bosquiazzo et al. (2010) studied the effects of the subcuta-
neous administration of BPA (0.05 or 20mg/kg bw/day) in newborn
female rats, treated between postnatal days 1 and 7, on steroid reg-
ulation of vascular growth factor expression and endothelial cell
proliferation in the adult rat uterus (>90 days of age). The results
of this study were not considered of concern because of major
methodological flaws and the non relevance of the route of admin-
istration for dietary risk assessment. In addition, it was noticed
that rats were ovariectomized at 80 days of age and submitted to
hormonal replacement before uterine tissues were sampled.
Braun et al. (2009) examined the potential association between
prenatal BPA exposure and behaviour in young children based on
data from249mothers and their children. Prenatal exposure to BPA
was assessed through maternal urine collected between weeks 16
and 26 of pregnancy and at birth. Child behaviour was assessed at
2 years of age using the second edition of the Behavioural Assess-
ment System for Children (BASC-2), a 134-item parent-reported
assessment of a child’s adaptive and problematic behaviours in
community and home settings. The test is declined for three age
levels: preschool (ages 2–5), child (ages 6–11), and adolescent (ages
12–21). The authors concluded that prenatal exposure to BPA may
be associated with externalizing behaviours in 2-year-old children,
especially among females. However, numerous methodological
flawswere underlined by theWG.With respect to exposure assess-
ment, someurine sampleswere storedup to5years before analysis,
whereas stability of BPA in frozen urine was not demonstrated for
such a long time. Regarding the BASC-2, the authors used the low-
est limit of validity of the test (2 years). Scores were normalized to
a mean (±SD) of 50±10 during the national (U.S.A.) standardiza-
tion of the instrument. Scores in the 60–69 range are considered
“at risk,” and scores ≥70 are considered clinically significant. The
results of this study were not considered of concern by the WG,
since highest adjustedmean scorewas 53.9, e.g. within the range of
average responses that are indicative of normal behaviour (41–59).
Moreover Longnecker (2009) also expressed some reservation on
the results of this study: although the sexual dimorphism of exter-
nalizing behaviour is widely recognized, absolute differences in
externalized scores associated with BPA cannot be determined
using the sex-standardized data presented.
Fernández et al. (2009) investigated the effects of BPA expo-
sure during the 10 first days of life on reproductive parameters and
the gonadotropin releasing hormone signaling in female rats, com-
bining in vivo and in vitro assays (on cells from animals treated
with BPA). The results of this study were not considered of con-
cern by the WG because of major methodological flaws, such as
the non relevance of the route of administration (subcutaneous)
and because most of the effects were only observed at the highest
dose (500g/50L, approximatelyequivalent to25–62mg/kgbw),
which is far above the NOAEL of 5mg/kg bw/day used for deriving
the current TDI.
Izzotti et al. (2009) measured DNA adducts in liver and
mammary cells of female mice receiving BPA in drinking water
(200mg/kg bw) for 8 days. Levels of DNA adducts were very low
according to thehighdose testedandwere thereforenot considered
of concern by the WG.
Li et al. (2010) concluded that BPA-exposed workers exhibited
higher risk of male sexual dysfunction than unexposed workers
(reduced sexual desire, erectile difficulty, ejaculation difficulty and
reduced satisfaction with sex life). However, data were obtained
by self-reporting, without supporting clinical data and can conse-
quently be questioned. In addition, occupational exposure mainly
took place through inhalation, which is of limited value for the
general population, orally exposed to lower doses of BPA.
Monje et al. (2009) studied the effects of BPA exposure (0.05 or
20mg/kg bw) during the seven first days of life on hypothalamic
estrogen-dependent mechanisms that govern sexual behaviour in
the adult female rat. Behavioural parameters were measured in
only 5 animals tested 2 times over a 2-week period and tests were
performed for 10min or 10 mounts (which ever occurred first) via
videotape based on lordosis, ear wiggling, hopping, and darting
during the test. In addition, rats were ovariectomized at 85 days
of age and the route of administration (subcutaneous) was not rel-
evant. Consequently, results of this study were not considered of
concern.
Sargis et al. (2010) investigated effects of BPA on adipogenesis
in vitro using the 3T3-L1 cell line. This study performed in vitro
was exceptionally included in the review because the French NGO
considers this study as being of high interest. No detectable adipo-
genesis occurred when the preadipocytes were treated with BPA
alone. The promotion of adipocyte differentiation took place only
when dehydrocorticosterone (an agent of cell differentiation) was
added. Therefore, the results of this study were not considered of
concern.
Somm et al. (2009) evaluated the effects of BPA in drinking
water (1mg/l, equivalent to 70g/kg bw/day) on early adipose
storage in weaned rats following exposure of dams during gesta-
tion and lactation. Results suggest that perinatal exposure to BPA
could increase body weight. Although there are several limitations
in this study (limited number of litters, only one dose tested, inter-
pretation based on the pup instead of the litter), the WG agreed
with the authors that further studies are required to understand
the mechanisms of action.
Studies indicating warning signals
Studies considered as warning signals show subtle effects on
behaviour, reproductive tract or intestine and effects on repro-
duction or the reproductive tract. However, there are major
methodological flaws in these studies, as underlined below.
Subtle effects on behaviour
Following perinatal subcutaneous exposure of female monkeys
to10g/kgbw/dayof BPAduring gestation and suckling,Nakagami
et al. (2009) observed the alteration of 3 out of 14 behaviours in
pups, namely clinging, outward looking and social exploration. In
a review of several studies performed by their team in mice orally
exposed to 10g/kg bw/day of BPA, Palanza et al. (2008) concluded
that dams spent less time nursing and more time resting alone
(mainlybasedondata fromGioiosaet al., 2007).However, noeffects
on weaning weight were shown, suggesting an adequate level of
maternal care. In offspring, the authors indicated a reduction or
eliminationof the sexdifference inbehaviour (namely curiosity and
anxiety). The relevance of these effects in terms of human health
has not yet been established.
Subtle effects on the reproductive tract
Following perinatal exposure of rats to BPA by gavage (1.2
or 2.4g/kg bw/day) Salian et al. (2009a) noticed changes in
the expression of steroid receptor coregulators in the testis. The
effects persisted through 3 generations,whereas only F1 pupswere
exposed in utero and during suckling. In neonatal rats (1–5 postna-
tal day) subcutaneously treated with BPA doses ranging from 100
to 1600g/kg bw/day, Salian et al. (2009b) observed changes in
expression of Sertoli cell junctional proteins during juvenile and
adult life. But, the relevance of these effects in terms of human
health remains to be established.
Subtle effects on intestine
In ovariectomized rats orally exposed to 0.05 or 5mg BPA/kg
diet per day, Braniste et al. (2010) observed on the one hand a
decrease of the basal colonic paracellular permeability and on the
other hand an increase in epithelial tight junction sealing and in
pain sensitivity to colorectal stimuli. Following in utero and suck-
ling exposure through dams treated by gavage to 5mg/kg/day, the
basal colonic paracellular permeability is decreased and the proin-
flammatory response of colonic mucosa is increased in adults (only
in females). The limited number of doses tested in this study makes
its use difficult for risk assessment. The relevance of these effects
in terms of human health remains to be established.
Effects on reproduction and reproductive tract
In rats followingoral exposure of damsbygavage to 1.2 or 2.4g
BPA/kg bw/day, Salian et al. (2009c) observed an increased post
implantation loss, a decreased litter size, sperm count and motility
in F1 male offspring. Following subcutaneous exposure of neona-
tal rats (postnatal days 1–5) from 100 to 1600g BPA/kg bw/day,
Salian et al. (2009b) also observed a similar increase in post implan-
tation loss, a decrease in litter size and a change in sperm count
with, in addition, changed hormonal balances.
In rat from dams subcutaneously treated with BPA
(2.5–1000g/kg bw/day) during gestation, Murray et al.
(2007) observed the development of ductal hyperplasias and
of carcinomas of the mammary gland.
In mice from dams subcutaneously treated (gestational days
9–16) to 0.1–1000g BPA/kg bw/day, Newbold et al. (2009)
observed an increase in ovarian cysts, in progressive proliferative
lesions of the oviduct and in tumor incidence of reproductive tis-
sues.
The WG concluded that these studies should be considered as
warning signals because of the limited number of doses tested
in these studies and/or the inappropriate route of administration
(subcutaneous) that make their use difficult for risk assessment.
Comments on the major flaws of the studies indicating warning
signals
The majority of the above-mentioned studies indicating warn-
ing signals have strong limitations impeding conclusion in terms of
dietary risk assessment:
- The route of administration is not oral but subcutaneous
(Nakagami et al., 2009; Murray et al., 2007; Newbold et al., 2009;
Salian et al., 2009b).
- Only onedosewas tested, namely10g/kgbw/day (Palanza et al.,
2008; Nakagami et al., 2009) and 5mgkg/bw/day (Braniste et al.,
2010 for perinatal exposure). Consequently, no dose-response
relationship can be established.
- The effects are observed in ovariectomized rat (Braniste et al.,
2010) and are not easy to be extrapolated to humans.
- No positive control were used (all studies, except Salian et al.,
2009b,c; Braniste et al., 2010).
- No data on actual exposure of the offspring were provided (for
all oral studies). Rats exhibiting effects are indirectly exposed
through the dam during gestation and suckling, whereas the BPA
level in rat milk is not known.
- The diet could be a source of bias because of the presence of phy-
toestrogens in soy-based diet (Palanza et al., 2008), because it is
an in-housed prepared diet (Salian et al., 2009a,b,c) or because no
data are provided on the potential presence of endocrine disrup-
tors in feed (Nakagami et al., 2009).
- Similarly, no data are provided on the level of endocrine disrup-
tors in the bedding (Braniste et al., 2010). Such data could be
of upmost importance when the bedding is composed of corn
cob (Palanza et al., 2008), puddy husk (Salian et al., 2009a,b,c) or
hardwood chip (Newbold et al., 2009).
- The use of polycarbonate bottles for rat drinking water (Newbold
et al., 2009) could be a source of BPA.
Conclusions of the Working Group
So far, toxicity studies on BPA performed in compliance with
international standards have not demonstrated any risk to human
health at the current levels of exposure. Other studies, performed
according to various protocols, observed effects following in utero
and postnatal exposures at doses lower than 5mg/kg bw/day.
However, these studies have major flaws and/or the relevance on
human health of the effects has not yet been demonstrated. Con-
sequently, such data were interpreted by the French Agency as
warning signals. Furthermore, it is clearly essential to understand
the mechanisms of action of these warning signals, to establish
if they are associated with the oestrogenic activity of BPA, since
humans are also exposed to other estrogenic compounds in food,
both from chemical and natural origins. In this case, BPA should not
be considered alone, but as part of a mixture of endocrine active
substances.
On the other hand, sources of exposure to BPA other than food
contact materials should be more thoroughly investigated, as they
might be critical for consumers and for supporting the authorities
to take appropriate measures.
In themeantime, the German Institute for Risk Assessment (BfR,
2010) and the DTU Fødevareinstituttets (2010) published updates
on BPA, including comments on the study by Stump (2009). The
BfR concluded that the results of this study (along with Ryan et al.,
2010) do not substantiate the concerns for a specific toxic potential
of BPAadverse toneurological andbehavioural development.How-
ever, the DTU stated that the Stump’s study gives rise to a degree
of uncertainty with regard to the effects on learning ability, since
impaired learning ability was found in male offspring with a low
dosage of BPA. The significance of the results on impaired learning
ability was not confirmed by the European Food Safety Authority
(EFSA) after a statistical re-analysis of data (EFSA, 2010). Following
a review of recent scientific literature and studies on the toxicity
of BPA at low doses, EFSA also concluded that there was no new
evidence which would lead to revise the current TDI for BPA of
0.05mg/kg body weight and that the data currently available do
not provide convincing evidence of neurobehavioural toxicity of
BPA. Regarding the studies that report adverse effects on animals
exposed toBPAduringdevelopment at doseswell below thoseused
to determine the current TDI, EFSA concluded, in agreement with
AFSSA, that they havemany shortcomings. The European Authority
did not interpret these data as warning signals but acknowledged
that the relevance of these findings for human health needs further
work. At the international level, the World Health Organization
(WHO) and the Food and Agriculture Organization of the United
Nations (FAO) jointly organized an expert meeting in November
2010 to review toxicological and health aspects of bisphenol A. The
expert meeting came to the same conclusion that there is no health
concern for many end-points. However, findings on emerging new
end-points should drive the direction of future research with the
objective of reducing uncertainty.
Derived from the case of BPA, the French experts issued the fol-
lowing recommendations for toxicity studies and risk assessment
associated with endocrine disruptors.
Studies designed to establish toxicological reference values
(as detailed in guidelines for regulatory toxicology tests) should
include:
- toxicokinetic parameters and particularly plasma and/or urine
concentrations to express internal doses especially in case of indi-
rect exposure through suckling;
- hormonal analysis (concentrations of hormones and their
metabolite(s) in blood and urine);
- investigation on the effects on physiological functions identified
as critical, depending on the development stage at the time of
exposure;
- consideration of methodological bias, such as the effects of diet
(e.g. the presence of phytoestrogens in soy-basedproducts), poly-
carbonate materials, the composition of the drinking water given
to the animals, the bedding (which may contain mycotoxins, ter-
penes, polyphenols, etc.).
- Several doses, including low doses, should be tested in order to
determine a dose–response relationship.
Moreover, the WG concluded that the assessment of poten-
tial health risks associated with low levels of endocrine disruptors
presupposes a new methodology. Indeed, such compounds can
have different effects depending on the development stage (crit-
ical exposure windows during which adverse effects can appear,
especially the perinatal period). In this context, the relevance of
the Tolerable Dietary Intake approach for risk assessment could
be questioned. By definition, the TDI is the maximum quantity of a
compound that can be consumeddaily over an entire lifetimewith-
out the risk of harmful effects on human health. The WG noted that
risk assessment of endocrine disruptors is especially complicated
due to:
- the nature of effects caused by compounds interacting with the
endocrine system;
- the nature of subtle effects in terms of human health, which
significance has to be established: sex difference in behaviour
of offspring (curiosity, anxiety, social exploration, clinging, out-
ward looking), time dams spent nursing, changes in expression of
coregulators or proteins, intestinal permeability/pain sensitivity,
. . .;
- suggested non-monotonic dose–response relationship;
- potential lack of a threshold for effect;
- effects at very low doses;
- exposure window: adverse effects following exposure on imma-
ture systems;
- potential delayed effects.
In the meantime, the calculation of margins of exposure (MOE)
could be used as a tool for prioritizing endocrine disruptors. Mar-
gins would be estimated based on the Lowest Observed Adverse
Effect Level (LOAEL) in the most sensitive animal species or human
data on the one hand, and the estimated human exposure on the
basis of dietary intake or biomonitoring data for different sub-
populations (pregnant women, infant, young children, adults) on
the other. This approach avoids the need to determine a safety fac-
tor a priori and allows taking into account the specific sensitivity of
humans at different stage of life by using different LOAELs. How-
ever, this approach cannot be applied to bisphenol A before the
significance of the warning signals has been clearly established. In
conclusion, the mobilization of scientists at international level is
necessary to reach this goal, through the collaboration of academic
researchers and governmental bodies.
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